Table 1. Marginal means of ARS and ALP values of different groups and their effect over time (two-way ANOVA).
| −VE CT | +VE CT | S1 (PCL/Alg) | S2 (PCL/Alg/Ca) | S3 (PCL/Alg/Ca/n-HA) | P | |
|---|---|---|---|---|---|---|
| ARS | 0.0643±0.0163 | 0.1133±0.0210a | 0.1027±0.0187a | 0.1027±0.0183a | 0.1507±0.0253a,b,c,d | <0.001 |
| ALP | 1.031±0.171 | 0.563±0.094a | 0.772±0.129a,b | 1.063±0.177b,c | 1.068±0.178b,c | <0.001 |
a, significance vs. −ve control group; b, significance vs. +ve control group; c, significance vs. S1 group; d, significance vs. S2 group within each time period. P, probability P<0.05. ANOVA, analysis of variance; ARS, Alizarin red S; ALP, alkaline phosphatase; PCL/Alg, polycaprolactone/alginate; n-HA, nano-hydroxyapatite.